Sentences with phrase «for other commissions»

If she makes a film work it could mean visitors lingering longer than they have for other commissions.
On the old boundaries Labour could win an overall majority with a lead over the Tories of 3 %, but given they win far more seats in Scotland and Wales than the Tories do, we really will need to wait for the other Commissions» reports before we can make any estimates about how their target will change.
Further, it included an indemnification clause under which the purchasers and brokers agreed to defend seller for any other commission amount for which he was held liable.

Not exact matches

Cboe has been a notable crypto advocate on Wall Street, teasing additional futures markets for other cryptocurrencies and calling on the Securities and Exchange Commission to approve bitcoin - linked ETFs, as Business Insider first reported.
Unlike in other countries, though, U.S. advisers are not required to become fiduciaries, and many choose not to - often so they can rake in commissions for selling you products that might not quite satisfy the «best interest of the client» standard.
The security breach comes two months after Bitfinex was ordered to pay a $ 75,000 fine by the U.S. Commodity and Futures Trading Commission in part for offering illegal off - exchange financed commodity transactions in bitcoin and other digital currencies.
An adviser who earns a flat fee - such an hourly rate or a set percentage of your portfolio value - is much better aligned with you than an adviser who earns commissions for selling you particular mutual funds, insurance policies, or other products.
These risks and uncertainties include, among others: the unfavorable outcome of litigation, including so - called «Paragraph IV» litigation and other patent litigation, related to any of our products or products using our proprietary technologies, which may lead to competition from generic drug manufacturers; data from clinical trials may be interpreted by the FDA in different ways than we interpret it; the FDA may not agree with our regulatory approval strategies or components of our filings for our products, including our clinical trial designs, conduct and methodologies and, for ALKS 5461, evidence of efficacy and adequacy of bridging to buprenorphine; clinical development activities may not be completed on time or at all; the results of our clinical development activities may not be positive, or predictive of real - world results or of results in subsequent clinical trials; regulatory submissions may not occur or be submitted in a timely manner; the company and its licensees may not be able to continue to successfully commercialize their products; there may be a reduction in payment rate or reimbursement for the company's products or an increase in the company's financial obligations to governmental payers; the FDA or regulatory authorities outside the U.S. may make adverse decisions regarding the company's products; the company's products may prove difficult to manufacture, be precluded from commercialization by the proprietary rights of third parties, or have unintended side effects, adverse reactions or incidents of misuse; and those risks and uncertainties described under the heading «Risk Factors» in the company's most recent Annual Report on Form 10 - K and in subsequent filings made by the company with the U.S. Securities and Exchange Commission («SEC»), which are available on the SEC's website at www.sec.gov.
Among the others: Facebook is strengthening its process for reviewing ads, increasing the size of its election - integrity and security teams, and partnering with election commissions around the world.
Further information on these factors and other risks that may affect the company's business is included in filings it makes with the Securities and Exchange Commission from time to time, including its Form 10 - K for the year ended Dec. 31, 2017, Form 10 - Q for the quarter ended March 31, 2018, and in its other SEC filings.
Factors which could cause actual results to differ materially from these forward - looking statements include such factors as the Company's ability to accomplish its business initiatives, obtain regulatory approval and protect its intellectual property; significant fluctuations in marketing expenses and ability to achieve or grow revenue, or recognize net income, from the sale of its products and services, as well as the introduction of competing products, or management's ability to attract and maintain qualified personnel necessary for the development and commercialization of its planned products, and other information that may be detailed from time to time in the Company's filings with the United States Securities and Exchange Commission.
But the current reality is this: While the number of U.S. companies owned by women is increasing faster than those of other groups, those companies are responsible for just 6 percent of the country's employees and 4 percent of revenue, according to a 2012 report commissioned by American Express Open.
The Securities and Exchange Commission announced the action Tuesday against the company, which is now called Altaba after its email and other digital services were sold to Verizon Communications for $ 4.48 billion last year.
A broker, on the other hand, gets paid a commission for selling financial products.
For a more complete discussion of these and other risk factors, please see each of McDermott's and CB&I's annual and quarterly filings with the U.S. Securities and Exchange Commission (the «SEC»), including their respective annual reports on Form 10 - K for the year ended December 31, 20For a more complete discussion of these and other risk factors, please see each of McDermott's and CB&I's annual and quarterly filings with the U.S. Securities and Exchange Commission (the «SEC»), including their respective annual reports on Form 10 - K for the year ended December 31, 20for the year ended December 31, 2017.
The three defense companies have also donated more money in the 2018 election cycle than any other company in the industry, according to a new analysis from the Center for Responsible Politics, which draws on the Federal Election Commission's latest political - candidate - contribution report.
Farmers, on the other hand, prefer a much higher percentage of their compensation to be salary with a small commission built in for exceeding their goals.
Further, PDC urges you to carefully review and consider the cautionary statements and disclosures, specifically those under the heading «Risk Factors,» made in its Quarterly Report on Form 10 - Q, its Annual Report on Form 10 - K for the year ended December 31, 2016 (the «2016 Form 10 - K»), filed with the U.S. Securities and Exchange Commission («SEC») on February 28, 2017 and amended on May 1, 2018, and other filings with the SEC for further information on risks and uncertainties that could affect the Company's business, financial condition, results of operations, and prospects, which are incorporated by this reference as though fully set forth herein.
Actual results and the timing of events could differ materially from those anticipated in the forward - looking statements due to these risks and uncertainties as well as other factors, which include, without limitation: the uncertain timing of, and risks relating to, the executive search process; risks related to the potential failure of eptinezumab to demonstrate safety and efficacy in clinical testing; Alder's ability to conduct clinical trials and studies of eptinezumab sufficient to achieve a positive completion; the availability of data at the expected times; the clinical, therapeutic and commercial value of eptinezumab; risks and uncertainties related to regulatory application, review and approval processes and Alder's compliance with applicable legal and regulatory requirements; risks and uncertainties relating to the manufacture of eptinezumab; Alder's ability to obtain and protect intellectual property rights, and operate without infringing on the intellectual property rights of others; the uncertain timing and level of expenses associated with Alder's development and commercialization activities; the sufficiency of Alder's capital and other resources; market competition; changes in economic and business conditions; and other factors discussed under the caption «Risk Factors» in Alder's Annual Report on Form 10 - K for the fiscal year ended December 31, 2017, which was filed with the Securities and Exchange Commission (SEC) on February 26, 2018, and is available on the SEC's website at www.sec.gov.
Nova Scotia's Securities Commission accuses Potter and three other insiders of violating its Securities Act through stock manipulation and undisclosed trades, with hearings slated for early 2012.
Cook wrote that the government should drop the legal request and instead «form a commission or other panel of experts on intelligence, technology, and civil liberties, to discuss the implications for law enforcement, national security, privacy, and personal freedom.»
The Securities and Exchange Commission is the governing regulatory agency for registered investment advisors that manage more than $ 100 million in assets, while each state's securities regulators generally oversee other investment advisors.
But critics in the financial services industry say the rule would limit the ability of advisers to service clients who can not afford to pay for financial advice and must use products that carry commissions or other indirect costs.
When most fans think of agents, they think of the inspiration for the movie Jerry Maguire, Drew Rosenhaus, and other guys pulling in enormous commissions off giant player contracts.
Other political figures such as Minnesota Senator Amy Klobuchar have also called for investigations and Federal Trade Commission (FTC) scrutiny into Mylan.
«In other words the law has created an artificial barrier for data flows so it's difficult for the commission or regulators to put that right»
In July, the Commodity Futures Trading Commission approved a bid by a firm called LedgerX to open a clearinghouse for crypto - currency puts, calls, swaps and all sorts of other exotic contracts.
One attempt to launch a Bitcoin ETF was rejected by the U.S. Securities and Exchange Commission earlier this year, but plans for others are in the works.
Actual results, including with respect to our targets and prospects, could differ materially due to a number of factors, including the risk that we may not obtain sufficient orders to achieve our targeted revenues; price competition in key markets; the risk that we or our channel partners are not able to develop and expand customer bases and accurately anticipate demand from end customers, which can result in increased inventory and reduced orders as we experience wide fluctuations in supply and demand; the risk that our commercial Lighting Products results will continue to suffer if new issues arise regarding issues related to product quality for this business; the risk that we may experience production difficulties that preclude us from shipping sufficient quantities to meet customer orders or that result in higher production costs and lower margins; our ability to lower costs; the risk that our results will suffer if we are unable to balance fluctuations in customer demand and capacity, including bringing on additional capacity on a timely basis to meet customer demand; the risk that longer manufacturing lead times may cause customers to fulfill their orders with a competitor's products instead; the risk that the economic and political uncertainty caused by the proposed tariffs by the United States on Chinese goods, and any corresponding Chinese tariffs in response, may negatively impact demand for our products; product mix; risks associated with the ramp - up of production of our new products, and our entry into new business channels different from those in which we have historically operated; the risk that customers do not maintain their favorable perception of our brand and products, resulting in lower demand for our products; the risk that our products fail to perform or fail to meet customer requirements or expectations, resulting in significant additional costs, including costs associated with warranty returns or the potential recall of our products; ongoing uncertainty in global economic conditions, infrastructure development or customer demand that could negatively affect product demand, collectability of receivables and other related matters as consumers and businesses may defer purchases or payments, or default on payments; risks resulting from the concentration of our business among few customers, including the risk that customers may reduce or cancel orders or fail to honor purchase commitments; the risk that we are not able to enter into acceptable contractual arrangements with the significant customers of the acquired Infineon RF Power business or otherwise not fully realize anticipated benefits of the transaction; the risk that retail customers may alter promotional pricing, increase promotion of a competitor's products over our products or reduce their inventory levels, all of which could negatively affect product demand; the risk that our investments may experience periods of significant stock price volatility causing us to recognize fair value losses on our investment; the risk posed by managing an increasingly complex supply chain that has the ability to supply a sufficient quantity of raw materials, subsystems and finished products with the required specifications and quality; the risk we may be required to record a significant charge to earnings if our goodwill or amortizable assets become impaired; risks relating to confidential information theft or misuse, including through cyber-attacks or cyber intrusion; our ability to complete development and commercialization of products under development, such as our pipeline of Wolfspeed products, improved LED chips, LED components, and LED lighting products risks related to our multi-year warranty periods for LED lighting products; risks associated with acquisitions, divestitures, joint ventures or investments generally; the rapid development of new technology and competing products that may impair demand or render our products obsolete; the potential lack of customer acceptance for our products; risks associated with ongoing litigation; and other factors discussed in our filings with the Securities and Exchange Commission (SEC), including our report on Form 10 - K for the fiscal year ended June 25, 2017, and subsequent reports filed with the SEC.
The European Commission is taking legal action against Ireland and Luxembourg for allegedly giving sweetheart tax deals to companies like iPhone maker Apple and burger chain McDonalds that allowed them to shift profits from other EU nations.
Kalanick went on to commission an «urgent» investigation into the allegations, to be headed by former U.S. attorney general Eric Holder and including, among others, Uber board member Arianna Huffington and the company's chief HR officer Liane Hornsey (who has only been on the job for a few months).
In a filing with the U.S. Securities and Exchange Commission on Wednesday, Disney ran through a list of Iger's accomplishments as CEO in 2015, including «record - breaking enthusiasm» for Star Wars: The Force Awakens, as well as other box office hits such as Pixar's Inside Out and Marvel's Avengers sequel.
On paper, it's easy to make a case for a three - or four - year time horizon - long enough for appreciation to offset the real estate agent's commission and other costs of buying and selling.
Airlines often pay a distribution fee and commissions for fares that are listed on websites other than their own.
The rule is intended to discourage brokers and other financial professionals from putting retirement - plan assets into products that pay high commissions or profit - sharing compensation to the brokers — a practice that's currently legal as long as the investments can be portrayed as «suitable» for the customer.
For those who aren't directly involved with clients, there are other ways to enhance salary: They earn a commission when they refer an employee to the company — which accrues every year that hire stays — or take a share of the fees when they refer clients.
These risks and uncertainties include: Gilead's ability to achieve its anticipated full year 2018 financial results; Gilead's ability to sustain growth in revenues for its antiviral and other programs; the risk that private and public payers may be reluctant to provide, or continue to provide, coverage or reimbursement for new products, including Vosevi, Yescarta, Epclusa, Harvoni, Genvoya, Odefsey, Descovy, Biktarvy and Vemlidy ®; austerity measures in European countries that may increase the amount of discount required on Gilead's products; an increase in discounts, chargebacks and rebates due to ongoing contracts and future negotiations with commercial and government payers; a larger than anticipated shift in payer mix to more highly discounted payer segments and geographic regions and decreases in treatment duration; availability of funding for state AIDS Drug Assistance Programs (ADAPs); continued fluctuations in ADAP purchases driven by federal and state grant cycles which may not mirror patient demand and may cause fluctuations in Gilead's earnings; market share and price erosion caused by the introduction of generic versions of Viread and Truvada, an uncertain global macroeconomic environment; and potential amendments to the Affordable Care Act or other government action that could have the effect of lowering prices or reducing the number of insured patients; the possibility of unfavorable results from clinical trials involving investigational compounds; Gilead's ability to initiate clinical trials in its currently anticipated timeframes; the levels of inventory held by wholesalers and retailers which may cause fluctuations in Gilead's earnings; Kite's ability to develop and commercialize cell therapies utilizing the zinc finger nuclease technology platform and realize the benefits of the Sangamo partnership; Gilead's ability to submit new drug applications for new product candidates in the timelines currently anticipated; Gilead's ability to receive regulatory approvals in a timely manner or at all, for new and current products, including Biktarvy; Gilead's ability to successfully commercialize its products, including Biktarvy; the risk that physicians and patients may not see advantages of these products over other therapies and may therefore be reluctant to prescribe the products; Gilead's ability to successfully develop its hematology / oncology and inflammation / respiratory programs; safety and efficacy data from clinical studies may not warrant further development of Gilead's product candidates, including GS - 9620 and Yescarta in combination with Pfizer's utomilumab; Gilead's ability to pay dividends or complete its share repurchase program due to changes in its stock price, corporate or other market conditions; fluctuations in the foreign exchange rate of the U.S. dollar that may cause an unfavorable foreign currency exchange impact on Gilead's future revenues and pre-tax earnings; and other risks identified from time to time in Gilead's reports filed with the U.S. Securities and Exchange Commission (the SEC).
10 — Apple gets conditions at least as beneficial — or even more beneficial — as other competitors for the price without contract, quality of service, commissions to salespeople, loaner cost, and limitations on customer service.
Chapdelaine and other local officials said they backed moratoriums because they were waiting for the state Cannabis Control Commission to finalize regulations and wanted to include residents in a conversation about where marijuana facilities belong.
I would then compare it to other places where there were commissions for the salespeople and incentives for them to better the company.
An advisor who earns a flat fee — such an hourly rate or a set percentage of your portfolio value — is much better aligned with you than an advisor who earns commissions for selling you particular mutual funds, insurance policies, or other products.
Factors that could cause or contribute to actual results differing from our forward - looking statements include risks relating to: failure of DBRS to rate the Notes at the anticipated ratings levels, which is a closing condition, or at all; changes in the financial markets, including changes in credit markets, interest rates, securitization markets generally and our proposed securitization in particular; the willingness of investors to buy the Notes; adverse developments regarding OnDeck, its business or the online or broader marketplace lending industry generally, any of which could impact what credit ratings, if any, are issued with respect to the Notes; the extended settlement cycle for the scheduled closing on April 17, 2018, which may exacerbate the foregoing risks; and other risks, including those described in our Annual Report on Form 10 - K for the year ended December 31, 2017 and in other documents that we file with the Securities and Exchange Commission from time to time which are or will be available on the Commission's website at www.sec.gov.
Important factors that could cause actual results to differ from OnDeck's forward - looking statements are the risks that OnDeck may not be able to manage its anticipated or actual growth effectively, that its credit models do not adequately identify potential risks, and other risks, including those under the heading «Risk Factors» in OnDeck's Annual Report on Form 10 - K for the year ended December 31, 2016, its Quarterly Reports for the quarters ended June 30 and September 30, 2017 and in other documents that OnDeck files with the Securities and Exchange Commission, or SEC, from time to time which are available on the SEC website at www.sec.gov.
Ideally, the United States would commit to holding the next EU-U.S. Energy Council gathering in 2017, and would explore the opportunity for a revitalized Export - Import Bank to cooperate with the European Commission and the European Investment Bank on co-financing LNG import terminals and other strategic infrastructure on the continent.
Before you decide, you'll want to know what kind of commission fees the broker charges to buy or sell stock (most are $ 7 - 9 per trade) and you should be sure to keep an eye out for maintenance charges or other monthly fees that the broker might charge for things like minimum account balances, etc..
They do NOT accept commission on products sold or any other forms of compensation from third parties, eliminating conflicts of interest related to compensation and allowing for objective advice.
Bias sometimes occurs when a broker gives financial advice that benefits the broker — such as in the form of a commission for selling specific mutual funds and other products.
The same pattern is true for other big BlackRock funds, according to a Reuters analysis of U.S. Securities and Exchange Commission filings from three of BlackRock's five largest funds.
The commissions fell even though the BlackRock fund routed roughly the same level of transactions to brokerages in exchange for access to their research notes and other related services.
A move by British regulators to ban financial advisers from accepting commissions for selling mutual funds and other products after 2012 is likely to cause lot of soul searching elsewhere, including in Canada.
a b c d e f g h i j k l m n o p q r s t u v w x y z